ARCHIVES

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Symposium Planned On Hyperthermia

April 23, 1976

Satraplatin Improved PFS In Refractory Prostate Cancer

July 25, 2003

In Brief: Barbara Britt Assumes ONS Presidency, O’Conner Is President-Elect; Kalt Joins NCI

May 25, 1990

TTF Increased Survival Compared To Chemotherapy

December 31, 2010

NCI director apologizes to cancer centers for inaction on working group report.

October 31, 2003

Kennedy Bill Would Extend Cancer Program Three Years, Kill Budget Bypass

May 4, 1979